Guardant Health, Inc. Common Stock
Veridion Score
Composite trend over time
Why is GH moving today?
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for GH.
GH insider activity
Guardant Health, Inc. Common Stock
3 insiders bought in the last 90 days
Net selling: -$59.6M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-23 | 2026-06-22 | Tariq Musa | Insider | sell | $131.16 | 1,951 | 11,048 | $256K | SEC Form 4 |
| 2026-06-23 | 2026-06-22 | POTTER MYRTLE S | Insider | sell | $131.16 | 1,556 | 20,971 | $204K | SEC Form 4 |
| 2026-06-17 | 2026-06-15 | Kalia Kumud | Insider | sell | $129.82 | 314 | 41,414 | $41K | SEC Form 4 |
| 2026-06-16 | 2026-06-16 | Tariq Musa | Insider | sell | $130.19 | 116 | 8,796 | $15K | SEC Form 4 |
| 2026-06-16 | 2026-06-15 | Freeman Chris | Insider | sell | $129.82 | 594 | 61,101 | $77K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 61 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moGH contract awards, year to date.
Public federal awards linked to this ticker.
GH lobbying filings, year to date.
Registered lobbying filings matched to Guardant Health, Inc. Common Stock.